Sensory Mechanisms of Manual Dexterity Recovery After Stroke: a Prospective Cohort Study of Prediction and Cerebral Correlates
NCT ID: NCT07340736
Last Updated: 2026-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
90 participants
INTERVENTIONAL
2026-03-01
2028-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Manual Dexterity Control After Cerebellar Stimulation
NCT03092570
Post-stroke Haptic Feedback Use Deficit: A Comparative and Reliability Study
NCT06344221
Hand Rehabilitation Study for Stroke Patients
NCT03148106
Simultaneous Recording of Cognitive and Motor Functions After Stroke
NCT05454748
Biomarkers for Prediction of Hand Function After Stroke - The ProHand Study
NCT02878304
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During each of the three visits, we will also administer validated sensory, motor, and cognitive clinical assessments, as well as anatomical, resting-state functional, and diffusion MRI sequences to investigate brain structure and function in relation to this haptic facilitation. These longitudinal measurements will enable the development of biomarkers of motor recovery of manual dexterity after stroke, with the primary objective of improving the prediction of dexterity recovery using a regression model.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stroke patients in the early subacute phase
Patients will be followed for 6 months over three visits. They will undergo validated sensory, motor, and cognitive clinical assessments, as well as MRI scans and manual dexterity tests performed with and without the addition of vibratory stimulation to the fingers, using a tool previously developed as part of this project.
Haptic stimulation device
Both patients and healthy participants will perform manual dexterity tasks using the Dextrain Manipulandum. In addition, they will receive finger vibrations delivered via rings that we have previously developed. These vibrations will have a frequency of 150 Hz and will be delivered for a duration of 150 ms.
Brain MRI
Subjects and patients will undergo anatomical, resting-state functional, and diffusion brain MRI sequences.
Healthy controls matched in age, sex and laterality with stroke patients
Healthy control participants will be assessed during a single visit. They will undergo motor, sensory, and cognitive clinical assessments, as well as manual dexterity tasks performed with and without the addition of finger vibrations using a previously developed tool. They will also undergo anatomical, resting-state functional, and diffusion brain MRI sequences. Each healthy participant will be matched to a patient in terms of age, sex, and handedness of the affected limb. For example, if we include a 60-year-old male post-stroke patient who is right-handed and has a right upper-limb impairment, we will include a healthy male participant aged 60 ± 5 years who is also right-handed.
Haptic stimulation device
Both patients and healthy participants will perform manual dexterity tasks using the Dextrain Manipulandum. In addition, they will receive finger vibrations delivered via rings that we have previously developed. These vibrations will have a frequency of 150 Hz and will be delivered for a duration of 150 ms.
Brain MRI
Subjects and patients will undergo anatomical, resting-state functional, and diffusion brain MRI sequences.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Haptic stimulation device
Both patients and healthy participants will perform manual dexterity tasks using the Dextrain Manipulandum. In addition, they will receive finger vibrations delivered via rings that we have previously developed. These vibrations will have a frequency of 150 Hz and will be delivered for a duration of 150 ms.
Brain MRI
Subjects and patients will undergo anatomical, resting-state functional, and diffusion brain MRI sequences.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Upper limb paresis (≤4/5 MRC Scale)
* Ability to grasp, lift and put down 1 block (from the BBT test)
* Be affiliated to a social security
Exclusion Criteria
* Severe cognitive impairment and/or aphasia with inability to understand and carry out instructions
* Contraindications to MRI (claustrophobia, presence of cochlear implants and/or pacemakers)
* Persons subject to legal protection measures
* Persons subject to judicial protection measures
* Pregnancy
* Life-threatening conditions or conditions requiring follow-up at 6 months
* Epilepsy
* Known hypersensitivity or allergy to silicone
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier St Anne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GHU Psychiatrie et Neurosciences
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A00115-44
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.